SMOFlipid 20% emulzija za infuziju
| Name | SMOFlipid 20% emulzija za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-039535852 |
| Active Substance | sojino ulje, rafinirano trigliceridi, srednje duljine lanca maslinovo ulje, rafinirano riblje ulje, obogaćeno omega-3 kiselinama |
| Composition | 1000 ml emulzije za infuziju sadrži: sojino ulje, rafinirano 60,0 g, trigliceridi, srednje duljine lanca 60,0 g, maslinovo ulje, rafinirano 50,0 g i riblje ulje, obogaćeno omega-3 kiselinama 30,0 g |
| Pharmaceutical Form | emulzija za infuziju |
| Manufacturer | Fresenius Kabi Austria GmbH, Graz, Austrija |
| Marketing Authorisation Holder | Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska |
| Marketing Authorisation Date | 18.10.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/519 |
| Registration Number | 381-12-01/30-17-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BA02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o potrebi zaštite otopina za parenteralnu prehranu od svjetlosti radi umanjivanja rizika od ozbiljnih nuspojava u nedonoščadi | 02.09.2019 | Fresenius Kabi d.o.o., Baxter SAS |
